Evidence map›Paper›PMID 38574301›Full record

ArticleJCO global oncology2024

Pan-Canadian Survey of Radiation Oncology Professional Involvement in Global Oncology Initiatives in Low- and Middle-Income Countries.

Matthew Beckett, Mustafa Al Balushi, Jessica Chan, Victor Iakovenko, Michael Roumeliotis, Tim Hanna, Fleur Huang, Maroie Barkati, Danielle Rodin, Jean-Marc Bourque

Erratum issuedAbstract read
In one paragraph

Article in JCO global oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Matthew BeckettDivision of Radiation Oncology, The Ottawa Hospital, Ottawa, ON, Canada.ORCID 0000-0002-4711-1002
Mustafa Al BalushiDepartment of Oncology, University of Alberta, Edmonton, AB, Canada.
Jessica ChanDivision of Radiation Oncology, University of British Columbia, Vancouver, BC, Canada.
Victor IakovenkoOdette Cancer Centre, Toronto, ON, Canada.
Michael RoumeliotisDepartment of Physics and Astronomy, University of Calgary, Calgary, AB, Canada.ORCID 0000-0003-2429-0690
Tim HannaCancer Research Institute, Queens University, Kingston, ON, Canada.ORCID 0000-0003-3228-6042
Fleur HuangDepartment of Oncology, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0001-7487-9642
Maroie BarkatiDepartement de Radio-oncologie, Université de Montréal, Montreal, QC, Canada.ORCID 0000-0002-0860-6125
Danielle RodinDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-8279-0621
Jean-Marc BourqueDepartement de Radio-oncologie, Université de Montréal, Montreal, QC, Canada.ORCID 0000-0001-9156-1409

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCanadian radiation oncology professionals have a strong history of involvement in global oncology initiatives worldwide. This pan-Canadian survey-based study was conducted to determine the current level of engagement of Canadian radiation oncologists (ROs) and medical physicists (MPs) in global oncology initiatives and broaden the development of these activities. MATERIALS AND

methodsThis was a cross-sectional study. The survey was designed to characterize current levels of engagement of Canadian ROs and MPs in global oncology initiatives. The survey was open from March 2019 to April 2020. It was disseminated to all Canadian Association of Radiation Oncology and Canadian Organization of Medical Physicists members with two subsequent email reminders.

resultsSurvey responses were received from 40 (93%) of the 43 Canadian cancer treatment centers that offer radiotherapy. At least one RO responded at 34 centers (79%) and one MP from 34 centers (79%) with some overlap. A response was received from a total of 93 participants, 47 ROs and 46 MPs. Of all survey participants, 58% reported some experience with global oncology. Nineteen percent of the participants surveyed were currently directly involved in short- or long-term projects, more than half of which have opportunity for additional staff involvement. The projects spanned 26 countries in South America, Africa, and Asia. Quality improvement and capacity building accounted for 27% and 20% of initiatives, respectively. The most common area of engagement was in direct treatment care, accounting for 56% of the projects.

conclusionThis study demonstrates the landscape of involvement of Canadian ROs and MPs in global oncology initiatives. The study also highlights areas of opportunity for broadening international participation and collaboration as it relates to global oncology for Canadian radiation oncology professionals.

Indexed as

Radiation OncologyCanadaCross-Sectional StudiesDeveloping CountriesHumansReactive Oxygen SpeciesReactive Oxygen Species

Identifiers

PMID38574301
PMCPMC11003509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.